Defining clinically meaningful improvement in molluscum contagiosum

J Am Acad Dermatol. 2024 Feb;90(2):443-445. doi: 10.1016/j.jaad.2023.10.033. Epub 2023 Oct 21.

Authors

Tomoko Maeda-Chubachi¹, Lori McLeod², Carolyn Enloe³, Martina Cartwright³, Elaine Siegfried⁴, Adelaide A Hebert⁵, Nanette Silverberg⁶

Affiliations

¹ Novan Inc, Durham, North Carolina. Electronic address: tmaeda-chubachi@novan.com.
² RTI Health Solutions, Durham, North Carolina.
³ Novan Inc, Durham, North Carolina.
⁴ Division of Pediatric Dermatology, Saint Louis University School of Medicine, Saint Louis, Missouri.
⁵ Department of Dermatology, UTHealth McGovern Medical School, Houston, Texas.
⁶ Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.

PMID: 37871806
DOI: 10.1016/j.jaad.2023.10.033

No abstract available

Keywords: clinical meaningfulness; infectious diseases; molluscum contagiosum; nitric oxide; patient-reported outcome measures; pediatrics.

MeSH terms

Humans
Molluscum Contagiosum* / diagnosis
Molluscum contagiosum virus*